Page last updated: 2024-09-04

vatalanib and Cancer of the Thyroid

vatalanib has been researched along with Cancer of the Thyroid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eilles, C; Grimm, D; Infanger, M; Kossmehl, P; Kurth, E; Schoenberger, J1
Barber, SE; Bekele, BN; Jasser, SA; Kim, S; Mandal, M; Myers, JN; Yazici, YD1

Other Studies

2 other study(ies) available for vatalanib and Cancer of the Thyroid

ArticleYear
Effects of PTK787/ZK222584, a tyrosine kinase inhibitor, on the growth of a poorly differentiated thyroid carcinoma: an animal study.
    Endocrinology, 2004, Volume: 145, Issue:3

    Topics: Adenocarcinoma, Follicular; Angiogenesis Inhibitors; Animals; Cell Differentiation; Cell Line, Tumor; Extracellular Matrix Proteins; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Phthalazines; Protein-Tyrosine Kinases; Pyridines; Thyroglobulin; Thyroid Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2004
Growth inhibition of orthotopic anaplastic thyroid carcinoma xenografts in nude mice by PTK787/ZK222584 and CPT-11.
    Head & neck, 2006, Volume: 28, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Drug Therapy, Combination; Irinotecan; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phthalazines; Protein Kinase Inhibitors; Pyridines; Thyroid Neoplasms

2006